Amolyria × GEN Helvetia
Stronger together, never alone.
Alexandra Levy, founder of GEN Helvetia in Geneva, brings her expertise in neurophysiological regulation to Amolyria and tests the platform. Her perspective complements the fieldwork of Daria Egorova, psychologist and co-founder. A considered approach, built with several voices.
Why this partnership
Supporting a person is never the work of a single discipline. A digital companion available at any hour becomes more accurate when it is shaped by several perspectives: clinical practice, regulation and technology.
Amolyria has therefore partnered with Alexandra Levy, whose work is helping highly solicited people regain stable regulation. Her role: to bring her expertise alongside the fieldwork of Daria Egorova, co-founder, psychologist and visual art therapist, and to test the platform in real-life conditions, with the precision and measure that characterise her practice.
Who is GEN Helvetia
GEN offers non-medical regulation and performance support for executives, elite athletes and high-demand professions. Based at the Institut Médico-Chirurgical de Champel in Geneva, GEN relies on the Quertant method (Psycho-Sensory Culture), a non-verbal, progressive and measurable neurofunctional training.
Visit gen-helvetia.com · Read Alexandra Levy's bioWhat each brings
Alexandra Levy · GEN Helvetia
- Expertise in neurophysiological regulation and optimisation
- Field practice with highly solicited profiles
- A demanding eye, grounded in precision and measure
- Platform testing and user feedback
Daria Egorova · Amolyria
- Clinical fieldwork (psychologist, MA Psychology)
- Visual art therapy for children and adults
- Clinical framework of the platform
Amolyria
- Digital companion available 24/7, without judgement
- Platform in production, hosted in Europe
- nFADP and GDPR compliance
Each approach keeps its place and its scope. Together, they form a whole stronger than any of them alone.
How Alexandra contributes
Complementary expertise
A regulation practitioner's perspective that complements Daria Egorova's fieldwork and enriches how the platform supports, reassures and guides.
Usage testing
Alexandra Levy explores the platform, tests its journeys, tone and pace, then shares her observations with the team.
Continuous improvement
Her feedback informs how the service evolves, through regular exchanges with the Amolyria team.
This collaboration is expert feedback, complementary to Daria Egorova's clinical work. It is neither a medical nor scientific validation, nor a certification of the platform.
Our commitments
A considered approach
Every change is examined from several perspectives before it is released.
Complementarity
Amolyria complements the medical, psychological and community support network. It does not replace it.
Confidentiality
Tests are carried out on trial accounts. No real user data is shared with GEN Helvetia.
Transparency
The scope and limits of the platform are presented honestly.
No therapeutic claims
Amolyria describes support. It does not promise a cure.
My work is helping highly solicited people regain stable regulation. My expertise complements the fieldwork of Daria Egorova, psychologist: we are stronger together than each on our own. Testing Amolyria means checking that the platform supports people accurately and respectfully, without ever promising what it cannot deliver.
Alexandra Levy, founder of GEN Helvetia
No one supports others well in isolation. Daria Egorova's clinical work is the foundation of Amolyria. Alexandra Levy's expertise complements it with the rigour of a precision practice. Stronger together, and more thoughtful in our approach: Amolyria remains a complement, never a substitute.
Christophe Robert, co-founder and CEO of Amolyria